Back

Should 12 months of dual antiplatelet therapy still be the default recommendation after primary PCI?

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Personalised management after primary PCI for ST elevation myocardial infarction: unresolved issues ST-Elevation Myocardial Infarction (STEMI) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Stefan James

Uppsala University, Uppsala (Sweden)

4 More presentations in this session

Presentation thumbnail
When to use a pharmaco-invasive approach rather than primary PCI
Professor A. Kastrati (Munich, DE)
Slides Video
Presentation thumbnail
Should everyone receive complete revascularisation after primary PCI?
Assistant Professor B. Stahli (Zurich, CH)
Slides Video
Presentation thumbnail
How useful are risk scores in determining bleeding risk and antithrombotic therapy duration after primary PCI?
Doctor R. Colleran (Dublin 7, IE)
Slides Video
Presentation thumbnail
Personalised management after primary PCI for ST elevation myocardial infarction: unresolved issues - discussion
Video

Access the full session

Session thumbnail
Personalised management after primary PCI for ST elevation myocardial infarction: unresolved issues
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Following an acute coronary syndrome, the default duration of dual antiplatelet therapy should be 12 months: pro
thumbnail
Congress Session
Great Debate: following an acute coronary syndrome, the default duration of dual antiplatelet therapy should be 12 months
thumbnail
Congress Presentation
Discussant review - DUAL-ACS

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources